Green Signal Bio Pharma

Chennai, India Founded: 2005 • Age: 21 yrs
Manufactures BCG vaccines for global immunization and health applications.

About Green Signal Bio Pharma

Green Signal Bio Pharma is a Healthcare company based in Chennai (India) founded in 2005 by P Sundaraparipooranan. It manufactures BCG vaccines for global immunization and health applications. It operates on a B2B and Manufacturing and Supply model. Green Signal Bio Pharma has raised $6.07 million across 2 funding rounds. The company has 117 employees. Its Indian entity Greensignal Bio Pharma Private Limited reported revenue of β‚Ή26.42 Cr. Green Signal Bio Pharma offers products and services including BCG Vaccine (Freeze Dried) IP, BCG Vaccine (Freeze Dried) BP, and BCG ONCO for Immunotherapy. Its focus areas include Bio-Pharma, Vaccines, BCG Immunization and Therapeutics. Its competitors include Biological E and Serum Institute of India.

Company details

GreenSignal Bio Pharma Private Limited is a leading vaccine manufacturer in India, specializing in BCG vaccines for child immunization and immunotherapy. They produce high-quality, affordable products using advanced freeze-drying techniques and ensure global distribution. Based in Chennai, Tamil Nadu, the company focuses on social responsibility and has supplied vaccines to millions worldwide, addressing public health needs.

  • Headquarters Chennai, India
  • Employees 117
  • Founders P Sundaraparipooranan
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website gsbpl.com
  • Legal Name Greensignal Bio Pharma Private Limited
  • Date of Incorporation 21 Nov, 2005
  • Jurisdiction Chennai, Tamil Nadu, India
Key Metrics
  • Annual Revenue
    ₹26.42 Cr

    FY 2025 · +5% YoY

  • Net Loss
    -₹32.13 Cr

    FY 2025 · -122% margin

  • EBITDA
    -₹21.83 Cr

    FY 2025 · -83% margin

  • Total Equity Funding
    $6.07M (USD)

    in 2 rounds

  • Latest Funding Round
    $2.12M (USD), Angel Round

    Mar 2016

  • Employee Count
    117

Products & Services of Green Signal Bio Pharma

Green Signal Bio Pharma offers a comprehensive portfolio of products and services, including BCG Vaccine (Freeze Dried) IP, BCG Vaccine (Freeze Dried) BP, and BCG ONCO for Immunotherapy.

BCG Vaccine (Freeze Dried) IP
Vaccine Production

BCG vaccine for infant immunization against tuberculosis.

BCG Vaccine (Freeze Dried) BP
Vaccine Production

Freeze-dried BCG vaccine meeting British Pharmacopoeia standards.

BCG ONCO for Immunotherapy
Therapeutic Vaccines

Vaccine used for cancer immunotherapy treatments.

Funding Insights of Green Signal Bio Pharma

Green Signal Bio Pharma has successfully raised a total of $6.07M across 2 strategic funding rounds. The most recent funding activity was a Angel Round of $2.12 million completed in March 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $6.07M
  • Total Rounds 2
  • Last Round Angel Round β€” $2.12M
  • First Round $3.95M

    (Jan 2010)

All 2 funding rounds of Green Signal Bio Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2016$2.12MAngel Round––
–
Jan 2010$3.95MSeries A––
–

Board of directors of Greensignal Bio Pharma Private Limited (Green Signal Bio Pharma)

Greensignal Bio Pharma Private Limited is the primary company behind Green Signal Bio Pharma. The board of Greensignal Bio Pharma Private Limited currently have 2 directors; the longest-serving is Chandrasekaran Eklaspuram Sorubanandam, appointed in 2008. 13 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Chandrasekaran Eklaspuram Sorubanandam
DIN 02377328
Whole-time director06 Oct 200818 yrsGreensignal Bio Pharma Private Limited
Murali Pakshirajan
DIN 02277738
Managing Director06 Oct 200818 yrsGreensignal Bio Pharma Private Limited

People of Green Signal Bio Pharma

1 people are tracked at Green Signal Bio Pharma (1 in leadership); the tracked headcount is 117.

NameRoleGroup
P Sundaraparipooranan
FounderLeadership
Premium access

Complete people profiles for Green Signal Bio Pharma

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Green Signal Bio Pharma

Figures of Greensignal Bio Pharma Private Limited, the primary company behind Green Signal Bio Pharma, for FY 2025. Revenue was ₹26.42 Cr (+5% year on year). Net loss was -₹32.13 Cr (-122% margin). EBITDA was -₹21.83 Cr (-83% margin). Revenue has grown at a compounded annual rate of +24% over three years and +12% over five years.

  • ₹26.42 CrRevenue · FY 2025 · +5% YoY
  • -₹32.13 CrNet loss · -122% margin
  • -₹21.83 CrEBITDA · -83% margin
  • ₹369 CrPaid-up capital
  • 117Employees (provident fund records)
  • +24%Revenue CAGR, 3 years
  • +12%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Greensignal Bio Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for Green Signal Bio Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Green Signal Bio Pharma

3 dated milestones of Green Signal Bio Pharma across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded Green Signal Bio Pharma is founded.
  2. Funding First funding round of $3.9M.
  3. Funding Latest funding round, Angel Round, of $2.1M.

Competitors of Green Signal Bio Pharma

Green Signal Bio Pharma has 2 listed competitors in our database. They include Biological E and Serum Institute of India.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
biologicale.com1953Hyderabad, India6,099
Vaccines and therapeutics for multiple diseases are developed and marketed.
seruminstitute.com1966Pune, India6,617
Vaccines and immuno-biological drugs for infectious diseases are manufactured.
Premium access

Detailed competitors of Green Signal Bio Pharma

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Green Signal Bio Pharma

The website of Green Signal Bio Pharma (gsbpl.com) receives about 1.5K visits a month.

  • Monthly visits
    1.5K

    ▼ 22.8% vs previous month

Similar websites

Websites whose visitors overlap most with Green Signal Bio Pharma. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
chittorgarh.net
chittorgarh.net
100%
#335,905–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Green Signal Bio Pharma

Premium access

Complete news archive for Green Signal Bio Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Green Signal Bio Pharma

Green Signal Bio Pharma was founded in 2005 and raised its 1st funding round 5 years after it was founded.

Green Signal Bio Pharma is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.

Green Signal Bio Pharma is a funded company, having raised a total of $6.07M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.95M, raised on Jan 2010.

Green Signal Bio Pharma has 117 employees.

The primary company behind Green Signal Bio Pharma, Greensignal Bio Pharma Private Limited, reported revenue of β‚Ή26.42 Cr for FY 2025, up 5% year on year.

GreenSignal Bio Pharma Private Limited is a leading vaccine manufacturer in India, specializing in BCG vaccines for child immunization and immunotherapy. They produce high-quality, affordable products using advanced freeze-drying techniques and ensure global distribution. Based in Chennai, Tamil Nadu, the company focuses on social responsibility and has supplied vaccines to millions worldwide, addressing public health needs.

Green Signal Bio Pharma's top competitors include Serum Institute of India and Biological E.

Green Signal Bio Pharma offers BCG Vaccine (Freeze Dried) IP, BCG Vaccine (Freeze Dried) BP, and BCG ONCO for Immunotherapy.

Green Signal Bio Pharma operates through Greensignal Bio Pharma Private Limited.

The legal entities of Green Signal Bio Pharma currently have 3 directors, including Chandrasekaran Eklaspuram Sorubanandam, Murali Pakshirajan, Satyajit Dash.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available